SOURCE: Gilead Sciences
DESCRIPTION:
As ASH21 wraps up, Gilead’s Rohini Mehtani, Ph.D. reflects on the importance of the meeting, particularly for people living with higher-risk myelodysplastic syndrome.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
KEYWORDS: NYSE: GILD, Gilead Sciences
